Search All News
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.
Innovation and discovery are at the heart of Herbert Irving Comprehensive Cancer Center's mission to reduce the burden of cancer. Learn more in the HICCC's 2021 annual report.
- March 5, 2020
CancerFIT—a free exercise program at CUIMC for cancer patients and survivors—offers more than a physical workout, it also provides much-needed support and inspiration.
- February 24, 2020
Columbia biomedical engineers have designed a bacteria strain that seeks out solid tumors and safely delivers immunotherapies, resulting in tumor regression in mouse models.
- January 10, 2020
The three scientists honored by the 2019 Horwitz Prize played key roles in identifying and deciphering the PI3K pathway, which has led to new treatments for several types of cancer.
- December 2, 2019
By learning how contagious cancer spreads among shellfish, scientists hope to better understand how cancer metastasizes in people.
- November 19, 2019
Researchers at Columbia are tackling cancer disparities in northern Manhattan and surrounding areas through the National Cancer Institute’s network of community-based research programs.
- November 11, 2019
Columbia oncologists are bringing their latest techniques in precision medicine to veterans with advanced prostate cancer.
- October 23, 2019
Katherine Crew, MD, directs the Clinical Breast Cancer Prevention Program and cares for patients with breast cancer and women at high risk at Columbia University Irving Medical Center/NYP.
- October 18, 2019
Exercise may lower breast cancer risk in all women and young survivors underutilize fertility-preservation services: These are among recent breast cancer findings from Columbia scientists.
- October 11, 2019
Lisa Kachnic, MD, the new chair of radiation oncology at Columbia University Irving Medical Center, has helped pioneer techniques that deliver radiation therapy to cancer patients with more precision.
- August 8, 2019
A new drug that penetrates the protective barrier around pancreatic cancers and accumulates in malignant cells may improve current chemotherapy, a study in mice suggests.